Cybin Announces Publication of Sponsored Feasibility Study Validating Kernel’s Flow1 Neuroimaging Technology Measuring Psychedelic Effects on the Brain
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, commends Kernel, a leader in non-invasive neuroimaging, on their publication titled “Measuring acute effects of…
MaaT Pharma Joins Microbiome Therapeutics Innovation Group
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced that the Company is now a member of Microbiome…
Pioneering Technologies in Minimally Invasive Surgery by Topcon Corporation, Olympus Corporation, and Leica Microsystems Propel Growth in Global Surgical Stapling Devices Market – ResearchAndMarkets.com
The “Surgical Stapling Devices Market Size, Share & Trends Analysis Report By Product (Powered, Manual), By Type (Disposable, Reusable), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global surgical stapling…
LinkinVAX Completes First Batch Production of “PanCov”, Its Next Generation Multi-variant Vaccine Against Covid and Other Coronaviruses
LinKinVax, a clinical-stage biotechnology company, announced the manufacture and bottling of a GMP batch of its next generation pan-sarbecovirus vaccines, known as PanCov, designed to prevent COVID-19 and other known coronavirus diseases. This new protein-based vaccine is unique because it targets…
United States Remote Patient Monitoring Market Outlook & Forecast Report 2023-2028: Enhancing Patient Care – Manufacturers Focus on RPM Software & Apps – ResearchAndMarkets.com
The “U.S. Remote Patient Monitoring Market – Industry Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The U.S. remote patient monitoring market is expected to reach a value of $25.28 billion by 2028 from $13.4 billion in 2022, growing at a…
Nalu Medical, Inc. Presents Important New Clinical Data for PNS and SCS at ASPN 2023
Nalu Medical, Inc. (“Nalu”), a Carlsbad, California-based neurostimulation company that has miniaturized neurostimulation implants for the management of chronic intractable pain for both Peripheral Nerve Stimulation (PNS) and Spinal Cord Stimulation (SCS) indications, presented significant new data from several studies…
Henry Schein One Announces Dentrix Ascend API Exchange
Henry Schein One, a joint venture of Henry Schein Inc. and Internet Brands, announced today the launch of the Dentrix Ascend Application Programming Interface (API) Exchange, an information marketplace for software vendors to share their expertise with thousands of practices…
Henry Schein Medical Receives Supplier Legacy Award From Premier, Inc.
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), has received the 2023 Supplier Legacy Award from Premier, Inc., a leading health care improvement and technology company that unites an alliance of more than 4,400 U.S. hospitals and health systems and…
Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook
Novartis today announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent covering Entresto and combinations of sacubitril and valsartan, which expires in 2025 with its pediatric exclusivity. Novartis…
Baxter Launches Progressa+ Next Gen ICU Bed to Help Address Complex Critical Care Needs
Baxter International Inc. (NYSE:BAX), an innovator in connected beds for med-surg and the intensive care unit (ICU), announced today the U.S. launch of its new Hillrom Progressa+ bed for the ICU. Progressa+ offers new technology and features that help make it easier for nurses…
CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition
CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of a $39 million equity financing led by MVM Partners with participation from Sectoral Asset Management and other existing investors. The company also announced that…
DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting
DermaSensor, a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented to the 11th Annual American Dermoscopy Meeting a sub-analysis of the DERM-ASSESS III study data focusing on…